Examination Report |
1 | User Affidavit | 20 Jun 2019 |
10 | Annexure -1 under rule 46 | 09 May 2023 |
2 | TM-A(TRADE MARKS APPLICATION) | 20 Jun 2019 |
3 | Reply to Exam Report (MIS-R) | 09 Sep 2019 |
4 | Reply to Exam Report (MIS-R) | 27 Nov 2019 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 07 Jun 2021 |
6 | Documents in support of Show cause Hearing (SCH) | 16 Jun 2021 |
7 | Journal Copy | 02 Feb 2022 |
8 | TM-O(NOTICE OF OPPOSITION) | 21 Mar 2022 |
9 | Evidence Affidavit Under Rule 46 (TOP) | 09 May 2023 |
1 | Dispatching of Examination Report for : 4211814 via Email | 8660442 | 4274828 | 26 Jul 2019 |
2 | Hearing Notice (Show Cause) | 9861797 | 03 Mar 2020 | |
3 | Hearing Notice (Show Cause) | 11460429 | 05 May 2021 | |
4 | Hearing Notice (Show Cause) | 11689337 | 21 Jun 2021 | |
5 | Hearing Notice (Show Cause) | 12217358 | 27 Sep 2021 | |
6 | Tribunal Accepted Notice for : 4211814 | 12530550 | 5384544 | 25 Nov 2021 |
7 | Opposition Notice | 14052071 | 5710179 | 07 Sep 2022 |
8 | Opposition Counter Statement | 14668115 | 5835380 | 20 Jan 2023 |
The application for Bg-zole was made on 20 June 2019.
The trademark applicant for Bg-zole is BLISS GVS PHARMA.
Bg-zole is applied in class(es) 5.
Application for Bg-zole is on Opposed stage.
Application Id allotted to Bg-zole is 4211814.
Trademark agent or attorney for the application is Innovative Consultants.
Bg-zole filed with the Intellectual property office as a WORD.